lobbying_activities: 2309176

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2309176	80259229-38d2-496e-afc3-5a6d4800f92e	Q2	FIERCE GOVERNMENT RELATIONS	401103500	ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)	2019	second_quarter	PHA	Issues relating to generic drugs, drug pricing, S. 340 - CREATES Act of 2019, Patent Abuse, S. 64- Preserve Access to Affordable Generics and Biosimilars Act, S. 1895- Lower Health Care Costs Act- Sec. 205, H.R. 965- CREATES Act of 2019	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2019-07-18T10:25:05.347000-04:00